Medications

Licencing deals struck for cheaper Pfizer COVID pill

Thirty-five generic drug manufacturers will make a more affordable version of Pfizer's anti-COVID pill for the world's poorer nations, in licensing deals announced Thursday by a UN-backed organisation.

Medical economics

Start talking about mRNA vaccine access now, say experts

While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world's most neglected infectious diseases say that conversations about access should begin now.

page 3 from 10